390: FDA turmoil, election intrigue, AI, and more
About this episode
Adam Feuerstein hosts the episode solo with guest Jared Holz, discussing various topics including FDA turmoil and biotech stock performance.
On "The Readout LOUD" this week: Adam Feuerstein, solo. His usual co-hosts Allison DeAngelis and Elaine Chen took some time off, so Adam manned the podcast mic himself. Adam thought, quite understandably, that our cherished listeners wouldn’t want to hear him drone on for 30 minutes, so he thankfully found some help. Jared Holz, health care sector specialist at Mizuho Securities, agreed to be Adam’s podcasting wingman for this week’s show.They ran through a menu of takes on biotech stock performance, M&A, Food and Drug Administration turmoil, election intrigue, and artificial intelligence.
People in this episode
Hosts: Adam Feuerstein, Elaine Chen
Guest: Jared Holz
Topics covered
- biotech stock performance
- M&A
- FDA turmoil
- election intrigue
- artificial intelligence
Keywords
- FDA
- biotech
- M&A
- election
- artificial intelligence
- health care
- stock performance
Mentioned in this episode
Organizations: Mizuho Securities, Food and Drug Administration
More episodes of The Readout Loud
- 398: A CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts
- 397: A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
- 396: A new trick for old science, and biotech VCs' scrambled playbook
- 395: Biotech investors' plea to Trump, and a busy M&A week
- 394: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy
- 393: A conversation with the 'godfather' of biotech
Explore listener stats, chart rankings, contacts and more on the The Readout Loud podcast page.